Status:
RECRUITING
A Prospective Birth Cohort of Infants With Allergy and Neurodevelopmental Disorders in China
Lead Sponsor:
Qilu Hospital of Shandong University
Conditions:
Child Allergy
Neurodevelopmental Disorders
Eligibility:
All Genders
1-42 years
Brief Summary
In this study, a birth cohort was established to demonstrate the causal relationship between allergies and neurodevelopment disorders in infants and young children, and to find out the influencing fac...
Detailed Description
In this study, a birth cohort was established, and infants were divided into two groups according to inclusion and exclusion criteria ( see study design ). One group was allergic group, and the other ...
Eligibility Criteria
Inclusion Criteria:
-
①Allergic questionnaire results were positive.
- The living area is Jinan City and its surrounding areas in Shandong Province, which is convenient for follow-up.
Exclusion Criteria:
-
There is a clear diagnosis of brain developmental disorders
-
Psychological diseases
- History of craniocerebral trauma or brain organic disease ④Major physical diseases ⑤Visual and auditory disorders ⑥ Epilepsy ⑦Intellectual disabilities
-
Key Trial Info
Start Date :
November 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 15 2029
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT06327906
Start Date
November 15 2023
End Date
November 15 2029
Last Update
March 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital of Shandong University
Jinan, Shandong, China